Cutia Therapeutics (HKG:2487)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8600
+0.0100 (1.18%)
Oct 9, 2026, 3:26 PM HKT

Cutia Therapeutics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-281.2-340.19-433.81-1,964-555.84-319.58
Depreciation & Amortization
39.9641.0142.941.4718.79.79
Other Amortization
2.372.371.661.010.22-
Loss (Gain) From Sale of Assets
-0.970.360.25--
Loss (Gain) From Sale of Investments
18.568.96-21.56-1.72-7.685.2
Stock-Based Compensation
11.4125.7968.62132.35100.0341.11
Other Operating Activities
26.0336.410.661,415237.48137.65
Change in Accounts Receivable
-111.02-85.28-37.4-62.85-0.1-
Change in Inventory
32.097.26-32.82-25.32-18.19-1.8
Change in Accounts Payable
22-5.32-13.8464.821.560.42
Change in Unearned Revenue
---0.4---
Change in Other Net Operating Assets
15.8617.93-17.3617.94-32.37-32.66
Operating Cash Flow
-223.95-290.09-442.98-381.31-236.19-159.88
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.64-11.69-22.57-55.73-134.35-24.32
Sale of Property, Plant & Equipment
0.020.010.010.01--
Sale (Purchase) of Intangibles
-0.63-1.18-3.11-0.18-0.96-1.57
Investment in Securities
-16.61-31.67328.59-176.13609.02-375.05
Other Investing Activities
4.5624.2513.1528.46-11.64-9.71
Investing Cash Flow
-17.3-20.28316.07-203.58462.07-410.65

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-268.52203.45189.2--
Long-Term Debt Repaid
--287.4-143.11-11.57-6.88-3.09
Lease Payments
-6.67-6.75-13.91-11.57-6.88-3.09
Net Debt Issued (Repaid)
-27.45-18.8860.34177.63-6.88-3.09
Issuance of Common Stock
226.29221.314.74422.52--
Repurchase of Common Stock
---13.86---
Other Financing Activities
-8.54-9.4-13.39-11.83-3.37-0.15
Financing Cash Flow
190.31193.0337.84588.32-10.25480.76

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-6.5-3.321.623.8247.11-7.27
Net Cash Flow
-57.43-120.66-87.457.25262.74-97.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-228.59-301.79-465.56-437.04-370.54-184.2
Free Cash Flow Growth
------
Free Cash Flow Margin
-68.73%-89.78%-166.50%-317.56%-3260.10%-9038.08%
Free Cash Flow Per Share
-0.65-0.91-1.52-2.14-4.63-2.30
Levered Free Cash Flow
-139.84-192.4-291.48-250.48-203.12-
Unlevered Free Cash Flow
-134.23-186.33-284.69-247.68-202.04-
Free Cash Flow After Leases
-235.26-308.53-479.46-448.62-377.43-187.28

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
6.367.127.41.8--
Change in Working Capital
-41.08-65.41-101.81-5.42-29.1-34.04